Clinical Trial

Insulin and Cognition in Patients with Psychotic Disorders

Study Description

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and healthy controls.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Intranasal Insulin

40 units Novolin R administered intranasally using ViaNase device.

Additional Information

Official Study Title

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

Clinical Trial ID

NCT03943537

ParticipAid ID

av2r8a